Shiraz Ladiwala
Vermögen: 869 516 $ am 31.05.2026
Vermögen: 869 516 $ am 31.05.2026
Shiraz S.
Ladiwala is currently Lead Independent Director at Mesa Laboratories, Inc. since 2022.
Former positions include Non-Executive Director at Patheon NV and Senior VP-Business Transformation Projects at Thermo Fisher Scientific, Inc. from 2020 to 2021.
Education includes an MBA from the University of Michigan and Stephen M.
Ross School of Business, and an undergraduate degree from the University of Mumbai.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.03.2026 | 8’523 ( 0.15% ) | 869 516 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MESA LABORATORIES, INC. | Direktor/Vorstandsmitglied | 28.10.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
| THERMO FISHER SCIENTIFIC, INC. | Corporate Officer/Principal | 31.03.2021 |
| PATHEON N.V. | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Mesa Laboratories, Inc.
Mesa Laboratories, Inc. Medical SpecialtiesHealth Technology Manufactures computer-based electronic measurement instruments | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Patheon NV
Patheon NV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical development and manufacturing services | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen